Portada Simposios - Supplements - Haematologica
Portada Simposios - Supplements - Haematologica
Portada Simposios - Supplements - Haematologica
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
XLII Reunión Nacional de la AEHH y XVI Congreso de la SETH. <strong>Simposios</strong><br />
265<br />
Table 1. Classification and distinguishing features of Congenital Dyserythropoietic Anemias (CDAs)<br />
Type Clinical features Morphology Inheritance<br />
I<br />
Anemia with neonatal<br />
appearance; jaundice,<br />
splenomegaly; rare syndactyly<br />
Common complication:<br />
hemochromatosis<br />
Anemia; jaundice; splenomagaly<br />
Hemochromatosis<br />
Gallstones<br />
Anemia mild to moderate;<br />
jaundice<br />
Gammopathy<br />
Severe or transfusion-dependent<br />
anemia with neonatal<br />
or infant appearance<br />
Megaloblastoid erythroid<br />
hyperplasia; nuclear bridges.<br />
ME: spongy-appearing nuclei<br />
and invagination of the<br />
cytoplasm in the nucleus<br />
2-4 nucleated late erythroblasts<br />
Karyorrhexis<br />
Auto-recessive<br />
Locus: 15q15.1-15.3<br />
II<br />
Auto-recessive<br />
20q11.2<br />
III<br />
Giant multinucleated<br />
erythroblasts<br />
Dominant<br />
15q22<br />
IV<br />
Marked normoblastic erythroid<br />
hyperplasia with a slight<br />
to moderate increase in the<br />
proportion of erythroblasts<br />
with very irregular or<br />
karyorrhectic nuclei.<br />
ME: Absence of precipitated<br />
protein within erythroblasts<br />
Marked normoblastic/slightly<br />
megaloblastic erythroid<br />
hyperplasia with little or no<br />
erythroid dysplasia<br />
Erythroid hyperplasia with<br />
vitamin B 12 -and<br />
folate-independent florid<br />
megaloblastic erythropoiesis<br />
Severe normoblastic erythroid<br />
hyperplasia with marked<br />
abnormalities in nuclear<br />
shape in many erythroblasts<br />
ME: Intraerythroblastic<br />
inclusions resembling<br />
precipitated -or -globin<br />
chains<br />
Recessive<br />
V<br />
Low grade anemia<br />
Jaundice with predominantly<br />
unconjugated<br />
hyperbilirubinaemia<br />
Normal or near-normal Hb with<br />
Marked macrocytosis<br />
Autosomal dominant or recessive<br />
VI<br />
Unknown<br />
VII<br />
Severe anemia with neonatal<br />
appearance and transfusion<br />
dependence<br />
Splenomegaly<br />
Normal MCV<br />
Recessive (probably)<br />
morphological abnormalities of the majority of<br />
erythroblasts in the bone marrow. Although a few<br />
reports had been published under various terms before,<br />
the first by Sansone from Genoa in 1949 2 , it<br />
was H. Heimpel that introduced this term in 1966,<br />
when he observed a pair of nonidentical 16 year old<br />
twin sisters with macrocytic anemia since early childhood,<br />
moderate splenomegaly and all laboratory<br />
findings of ineffective erythropoiesis. In the bone<br />
marrow, there was excessive erythroid hyperplasia<br />
with unusual morphological changes of almost all<br />
erythroblasts 3 .<br />
Heimpel proposed to preliminary classify these<br />
disorders into three types. These first classical types<br />
(I-III) differ in bone marrow erithroid morphology as<br />
well in the inheritance pattern (table 1).<br />
This classification since its appearance showed its<br />
limitated applicability and in fact there were some<br />
dyserythropoiesis that not fulfilled these strict diagnostic<br />
criteria causing the appearance of new groups<br />
(groups IV-VII). In the Wickramasinghe studies 4<br />
approximately one third of dyserytropoietic anemias<br />
are types other than I-III. Recently he identifies four<br />
additive groups reported in table 1. However it is noteworthy<br />
that each group may be genetically heterogeneous<br />
and that the group is proposed on the basis<br />
of the common phenotypic appearance.<br />
CDA-I<br />
The clinical picture of CDA-I was quite variable.<br />
The age at diagnosis varied from birth to early adulthood.<br />
Tamary observed the largest group of these<br />
patients (mainly of bedouin origin) and she demonstrated<br />
that the vast majority of the them with<br />
CDA type I were symptomatic during the neonatal<br />
period. Their manifestations included anemia, early<br />
jaundice, hepatosplenomegaly and cardiac manifestations.<br />
No bone abnormality was observed out of